Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...
Triumvira Immunologics’ $100 Million Series A Financing Round
Conavi Medical’s $20 Million Funding Round
Torys LLP acted as counsel to Conavi Medical in connection with the financing. On December 15, 2021, Conavi Medical Inc. entered into agreements for over US$20...
Swift Medical’s US$35 Million Series B Financing
Torys represented Swift Medical on the deal. Swift Medical announced a US$35 million Series B financing. The investment round was led by Virgo Investment Group LLC...
SeaSpine’s $110 Million Acquisition of 7D Surgical
Torys LLP represented 7D Surgical on the transaction. On May 20, 2021, SeaSpine Holdings Corporation announced the closing of the previously announced acquisition of all of...
SeaSpine’s $110 Million Acquisition of 7D Surgical
Torys LLP represented 7D Surgical on the transaction. On May 20, 2021, SeaSpine Holdings Corporation announced the closing of the previously announced acquisition of all of...